Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to understand the rate of progression of all stages of choroideremia using a variety of assessments performed in the clinic including visual field measures, specialized photography of the eye and participant-reported visual problems


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02994368
Study type Observational
Source 4D Molecular Therapeutics
Contact Paula Lea
Phone 510-505-2680
Email [email protected]
Status Recruiting
Phase
Start date December 2016
Completion date December 2022

See also
  Status Clinical Trial Phase
Completed NCT02553135 - Choroideremia Gene Therapy Clinical Trial Phase 2
Completed NCT01461213 - Gene Therapy for Blindness Caused by Choroideremia Phase 1/Phase 2
Active, not recruiting NCT03507686 - A Safety Study of Retinal Gene Therapy for Choroideremia With Administration of BIIB111 Phase 2
Recruiting NCT01866371 - High Resolution Retinal Imaging
Completed NCT01603576 - Pilot Study of a Suprachoroidal Retinal Prosthesis N/A
Enrolling by invitation NCT03584165 - Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa
Completed NCT03359551 - Natural History of the Progression of Choroideremia Study
Recruiting NCT02435940 - Inherited Retinal Degenerative Disease Registry
Recruiting NCT04483440 - Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia Phase 1
Completed NCT02671539 - THOR - Tübingen Choroideremia Gene Therapy Trial Phase 2
Completed NCT02670980 - Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy N/A
Active, not recruiting NCT02341807 - Safety and Dose Escalation Study of AAV2-hCHM in Subjects With CHM (Choroideremia) Gene Mutations Phase 1/Phase 2
Enrolling by invitation NCT03406416 - Study of a Suprachoroidal Retinal Prosthesis N/A
Terminated NCT01654562 - The Short-term Effects of Simvastatin on the Vision of Males Affected by Choroideremia Phase 1/Phase 2
Active, not recruiting NCT00427180 - IRIS PILOT - Extended Pilot Study With a Retinal Implant System N/A
Recruiting NCT04750785 - A Study to Assess Choroideremia (CHM) Health Outcomes
Completed NCT03496012 - Efficacy and Safety of BIIB111 for the Treatment of Choroideremia Phase 3
Completed NCT04795206 - Natural Disease Progression in Participants With Choroideremia
Active, not recruiting NCT02407678 - REP1 Gene Replacement Therapy for Choroideremia Phase 2
Active, not recruiting NCT02077361 - An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia Phase 1/Phase 2